We looked inside some of the tweets by @BU_Amyloidosis and found useful information for you.
Inside 100 Tweets
The average Twitter user has 126 followers.
We have an opening for July 1, 2020 for our 1-year cardiac #amyloidosis research fellowship at the BU/BMC Amyloidosis Center @BU_Amyloidosis. Any MD trained physician who has completed IM training is eligible. Details attached. Email with questions.
Incredible work from my colleagues! @BU_Amyloidosis @vsanchorawala @Jmarksloan Continung to expand rx for AL amyloidosis 👏🏼 Safety, Tolerability, and Response Rates of Daratumumab in Relapsed AL Amyloidosis: Results of a Phase II Study | https://ashpublications.org/blood/article/doi/10.1182/blood.2019004436/440750/Safety-Tolerability-and-Response-Rates-of#.XjEDq30zBYg.twitter …
Similar to results from @BU_Amyloidosis of 125 patients treated with IMiD on 3 different clinical trials, pooled analysis. With a median follow‐up of 8.4 years, Median OS is 4.3 years and median PFS is 2.1 years. https://www.ncbi.nlm.nih.gov/pubmed/31020691